Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors
Clinical trial NCT04525131 · COMPLETED
Trial details
- NCT number
- NCT04525131
- Sponsor
- CicloMed LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-25
- Primary completion
- 2022-12-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.